News
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (24)
- Nov (34)
- Dec (20)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Featured news
Latest news
IDIBAPS researchers detail the role played by certain microRNAs in the development of liver cirrhosis
Medical use of cannabis approved: in hospitals only and under specialist supervision
The Hospital Clínic Barcelona, recognized at the IQVIA TOP 20 2025 Awards
The Clínic Barcelona Comprehensive Cancer Center presents 52 scientific contributions at ESMO 2025
The Clínic Barcelona Comprehensive Cancer Center (4CB), a center promoted by Clínic, IDIBAPS and the University of Barcelona, has presented a total o1
Clínic Barcelona commemorates World Breast Cancer Day with a conference focused on patients’ wellbeing
The event addressed emotional, sexual, bureaucratic and research-related aspects, with a multidisciplinary and participatory approach.
Clínic-IDIBAPS study reveals brain connectivity changes in women with post-traumatic stress disorder after sexual assault
A team from Hospital Clínic-IDIBAPS has identified changes in brain connectivity in women who have recently experienced sexual assault and developed1
IDIBAPS endorses Comunitat Hipàtia’s recommendations for inclusive health research communication
IDIBAPS has taken a step forward in its commitment to equality and diversity by adopting the recommendations for inclusive communication in1
New treatments for atopic dermatitis
Current therapeutic advances allow more personalised, effective treatment for patients with moderate and severe atopic dermatitis.